Immunocytochemical localization of lymphatic and venous vessels in colonic polyps and adenomas

Digestive Diseases and Sciences

Volumn 53, Issue 7, 2008, Pages 1880-1885

  Tomita, Tatsuo ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Colon; Colonic adenoma; Factor 8; Lymphatic vessels; LYVE 1; Venous vessels

Indexed keywords

GLYCOPROTEIN; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOMA; COLON POLYP; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH VESSEL; MALE; PRIORITY JOURNAL; VILLOUS ADENOMA;

ADENOMA; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLONIC POLYPS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS; MALE; MIDDLE AGED; VEINS; VESICULAR TRANSPORT PROTEINS;

EID: 44449143598     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0078-9     Document Type: Article

References (16)

1. Zimmerman RL, Ross HM, Gausas RE (2004) Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 11:47-50
2. Fogt F, Pascha TL, Zhang PJ, Gausas RE, Rahemtulla A, Zimmerman RL (2004) Proliferation of D2-40 expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowl disease. Int J Mol Med 13:211-214
3. Kaiserling E, Krober S, Geleff S (2003) Lymphatic vessels in the colonic mucosa in ulcerative colitis. Lymphology 36:52-61
4. Parr C, Jiang WG (2003) Quantitative analysis of lymphangiogenic markers in human colorectal cancer. Int J Oncol 23:533-539
5. Gao F, Gao ML, Liu YW, He YQ, Wang Y (2006) Expression and quantification of LYVE-1 in human colorectal cancer. Cli Exp Med 6:65-71
6. Vainionpaa N, Butzow R, Hukkanen M, Jackson DG, Pihlajaniemi T, Kasai LY, Virtanen I (2007) Basement membrane protein distribution in LYVE-1 immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas. Cell Tissue Res 328(2):317-328
7. Tomita T (2007) LYVE-1 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors. Pancreas (in press)
8. Koukourakis MI, Giatromanolaki A, Sirridis E (2005) LYVE-1 immunocytochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 58:202-206
9. Rickert RR (1998) Papillary adenoma of the large intestine: a historical perspective. Cancer 83:825-829
10. Tomita T (1995) DNA ploidy and proliferating cell nuclear antigen in colonic adenomas and adenocarcinomas. Dig Dis Sciences 40:996-1004
11. Parr C, Jiang WG (2004) Quantitative analysis of lymphangiogenic markers in human colorectal cancer. Int J Oncol 23:533-539
12. Fiedler U, Christian S, Koidl S, Korjaschki D, Emmett MS et al (2006) The sialomucin CD 34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol 168:1045-1053
13. Sipos B, Klapper W, Kruse ML, Kaltoff H, Kaejaschki D, Kloppel G (2004) Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol 23:533-539
14. Wigel JT (1999) Prox-1 function is required for development of the mouse lymphatic system. Cell 98:769-778
15. Jassila L, Valtola TA, Partanen P, Salvan P, Heikkili MT (1998) Lymphatic endothelium and Kaposi's sarcoma spindle cell detected by antibodies against vascular endothelial growth receptor-3. Cancer Res 58:1599-1604
16. Navas V, O'Morchoe PJ, O'Morchoe CC (1995) Lymphatic system of rat pancreas. Lymphology 28:4-20